Search results
Showing 7546 to 7560 of 8314 results
NephroCheck test to help assess the risk of acute kidney injury in critically ill patients (MIB156)
This medtech innovation briefing has been updated and replaced by NICE HealthTech guidance 544.
EarlyCDT-Lung for cancer risk classification of indeterminate pulmonary nodules (MIB209)
This advice has been updated and replaced by NICE healthtech guidance 611.
FibroScan for assessing liver fibrosis and cirrhosis in primary care (MIB216)
This advice has been updated and replaced by NICE healthtech guidance 682.
Promonitor for monitoring response to biologics in rheumatoid arthritis (MIB126)
This advice has been replaced by NICE HealthTech guidance 521.
Point-of-care creatinine tests before contrast-enhanced imaging (MIB136)
This advice has been replaced by NICE HealthTech guidance 530.
This advice has been updated and replaced by NICE healthtech guidance 655.
This advice has been updated and replaced by NICE healthtech guidance 730.
QbTest for the assessment of attention deficit hyperactivity disorder (ADHD) (MIB318)
This advice has been updated and replaced by NICE healthtech guidance 729.
The BCM – Body Composition Monitor for managing fluid in people having dialysis (MIB41)
This advice has been updated and replaced by NICE guidance HTG441
Personal KinetiGraph for remote clinical management of Parkinson's disease (MIB258)
This advice has been updated and replaced by NICE healthtech guidance 657.
RapidAI for analysing CT/MRI brain scans in people with suspected acute stroke (MIB262)
This advice has been updated and replaced by NICE healthtech guidance 708.
Autologous haematopoietic stem cell transplantation for treating multiple sclerosis [ID1111]
Discontinued Reference number: GID-TA10306
Betibeglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID968]
Discontinued Reference number: GID-TA10334
Durvalumab with tremelimumab for untreated PD-L1-positive urothelial bladder cancer [ID1335]
Discontinued Reference number: GID-TA10315
Veliparib in combination for treating BRCA-positive, HER2-negative breast advanced cancer [ID1404]
Discontinued Reference number: GID-TA10327